Prostatis Group’s iShares Silver Trust SLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$300K Buy
4,398
+236
+6% +$17.9K 0.08% 141
2025
Q4
$268K Sell
4,162
-1,289
-24% -$64.5K 0.06% 145
2025
Q3
$231K Buy
+5,451
New +$196K 0.06% 155
2023
Q3
Sell
-13,307
Closed -$70.2K 214
2023
Q2
$70.2K Buy
+13,307
New +$296K 0.03% 154
2023
Q1
Sell
-25,321
Closed -$558K 110
2022
Q4
$558K Buy
+25,321
New +$496K 0.34% 58

Other funds holding SLV

Prostatis Group's SLV Position: Q1 2026 in Review

Prostatis Group increased its iShares Silver Trust (SLV) stake by 5.7% in Q1 2026, buying an estimated $17.9K and bringing the position to 4,398 shares worth $300K. The position accounts for 0.08% of the portfolio, ranked #141.

Prostatis Group first reported a position in SLV in Q4 2022 and has held it in 5 quarters since. The position peaked at $558K in Q4 2022. 1,552 funds tracked by Wall St. Rank hold SLV as of Q1 2026.

  • Prostatis Group held 4,398 shares of iShares Silver Trust worth $300K as of Q1 2026.
  • Prostatis Group bought 236 iShares Silver Trust shares in Q1 2026, an estimated $17.9K.
  • iShares Silver Trust made up 0.08% of Prostatis Group's portfolio in Q1 2026, its #141 holding.
  • Prostatis Group first reported a position in iShares Silver Trust in Q4 2022 and has held it in 5 quarters since.
  • Prostatis Group's iShares Silver Trust position peaked at $558K in Q4 2022.
  • 1,552 funds tracked by Wall St. Rank held iShares Silver Trust as of Q1 2026.

Based on Prostatis Group's 13F filing for Q1 2026, filed 12 May 2026.